Calcium-Channel Precision and Cardiovascular Resilience: Navigating the Nitrendipine Market Forecast
The global pharmaceutical and geriatric healthcare landscape of early 2026 is defined by a rigorous focus on the management of chronic hypertension and the prevention of coronary complications. Nitrendipine, a second-generation dihydropyridine calcium-channel blocker, has emerged as a cornerstone medication in this environment, valued for its high selectivity for vascular smooth muscle and its...
0 Comments 0 Shares 339 Views 0 Reviews